Search Articles — Sudonull

https://sudonull.com/claude-rewrote-bios-for-intel-bartlett-lake-on-z790

Learn how AI Claude bypassed Intel's lockout and ran server Core 9 273PQE on a desktop board. Details of BIOS modding, FSP-M, and Windows booting. For IT specialists.

https://sudonull.com/ai-driven-phage-therapy-locus-biosciences-clinical-trials

Breakthrough in superbug treatment: Locus Biosciences automated phage therapy with AI and CRISPR-Cas3 moves to clinical trials. Learn about the revolution in biopharmaceuticals.

https://sudonull.com/pc-without-ram-on-cpu-cache-how-to-run

Learn how to run a PC without RAM, using only processor cache. Experiment with BIOS, assembler and 'Snake'. Technical details for developers.

https://sudonull.com/proxmox-ve-for-home-assistant-migration-from-raspberry-pi

How to migrate Home Assistant from Raspberry Pi to Proxmox VE. Step-by-step instructions for installation, BIOS setup, and creating a fault-tolerant architecture. Learn more!

https://sudonull.com/starshade-for-searching-exoplanets

Hybrid observatory HOEE combines space starshade and ground telescopes ELT, GMT for direct imaging of Earth-like planets. Learn about contrast, resolution, and biosignatures. Explore research details.

https://ymaho.com/biosimilar-without-phase-3-fda-and-ema-rewrite-the-rules

FDA and EMA approved skipping Phase 3 for Herceptin biosimilar AP063. Learn how this decision will change the biosimilar market and accelerate access to cancer therapy.

https://ymaho.com/fda-approves-expansion-of-avastin-biosimilar-production

FDA approves expansion of Avzivi biosimilar production to 4000 L. Learn how this will lower bevacizumab prices and reshape the market. Detailed analysis.

https://ymaho.com/langlara-fda-approved-chinese-insulin-biosimilar

FDA approved interchangeable biosimilar insulin glargine Langlara from Chinese Sunshine Lake. Learn how this will change the US market and prices for patients. Detailed analysis inside.

https://ymaho.com/smart-biosensors-in-l-ore-al-foundations-analysis-and-risks

Analyzing L'Oréal's CES 2026 announcement: smart foundation with pH, hydration, and microbiome sensors. Price, subscription, errors, and forecasts. Read details.

https://ymaho.com/fda-approved-langlara-as-an-interchangeable-biosimilar-of-insulin-glargine

FDA granted Langlara interchangeable biosimilar status to Lantus. Learn how this will change the US insulin market and expand patient access to therapy.

https://ymaho.com/sam-altman-s-180m-investment-in-anti-aging-via-ai-and-cells

Analysis of Sam Altman's investments in Retro Biosciences, GPT-4b micro AI model, and cellular reprogramming. Real prospects, risks, and competitors. Read details.

https://ymaho.com/human-cell-rejuvenation-therapy-trials

Learn about the first clinical trial of ER-100 cell rejuvenation therapy from Life Biosciences. How epigenetic reprogramming can reverse aging. Read details.

https://ymaho.com/ozempic-face-correction-2026-protocols

How to fix 'Ozempic face' after GLP-1? Analysis of new protocols for biostimulation and skin density restoration. Learn about prevention and treatment.

https://ymaho.com/fasenra-approved-by-fda-for-treatment-of-hypereosinophilic-syndrome

FDA approved Fasenra (benralizumab) for HES therapy. 65% reduction in exacerbation risk and steroid-sparing effect. Learn how this changes the biosimilar market.

https://ymaho.com/pdrn-and-exosomes-a-new-standard-of-anti-age-care

Korean anti-age is shifting to PDRN and exosomes. Find out why cell regeneration is replacing retinol and how to choose a safe biostimulator.